Table 4. Liverpool resource recommendations for top medications reported to have interaction potential with boceprevir and telaprevir[21].
Medication | Classification* | Studied | Clear recommendation | Listed in prescribing information | |||||
---|---|---|---|---|---|---|---|---|---|
Boceprevir | Telaprevir | ||||||||
| |||||||||
N | I | C | N | I | C | BOC/TVR | BOC/TVR | BOC/TVR | |
zolpidem | X | X | No / Yes | No / Yes | No / Yes | ||||
alprazolam | X | X | Yes / Yes | Yes / Yes | Yes / Yes | ||||
amlodipine | X | X | No / Yes | Yes / Yes | Yes / Yes | ||||
prednisone | X | XC | Yes / No | YesPI / Yes | No / Yes | ||||
tramadol | X | X | No / No | No / No | No / No | ||||
codeine | X | X | No / No | Yes / Yes | No / No | ||||
fluticasone | XC | XC | No / No | Yes / Yes | Yes / Yes | ||||
methylprednisolone | X | XC | No / No | Yes / Yes | No / Yes | ||||
escitalopram | X | X | Yes / Yes | Yes / Yes | No / Yes | ||||
trazodone | X | X | No / No | Yes / Yes | Yes / Yes | ||||
clindamycin (systemic) | X | X | No / No | No / No | No / No | ||||
diazepam | X | X | No / No | No / No | No / No | ||||
sertraline | X | X | No / No | No / No | No / No | ||||
lansoprazole | X | X | No / No | No / No | No / No | ||||
clonazepam | X | X | No / No | No / No | No / No | ||||
sildenafil (Viagra only) | X | X | No / No | Yes / Yes | Yes / Yes | ||||
fluconazole | X | X | No / No | No / No | No / No | ||||
simvastatin | X | X | No / No | Yes / Yes | Yes / Yes | ||||
venlafaxine | X | X | No / No | No / No | No / No | ||||
salmeterol | XC | XC | No / No | Yes / Yes | Yes / Yes | ||||
clarithromycin | X | X | Yes / No | Yes / Yes | Yes / Yes | ||||
tacrolimus | X | X | Yes / Yes | Yes / Yes | Yes / Yes |
Abbreviations: N, None; I, Potential interaction; C, Contraindicated; BOC, Boceprevir; TVR, Telaprevir; PI, prescribing information
Interaction potential based on Liverpool Drug Interaction charts with None: “No clinically significant interaction expected”; Potential interaction: “Potential interaction – may require close monitoring, alteration of drug dosage or timing of administration; Contraindicated: “These drugs should not be coadministered”
Bold indicates drug also listed in Table 3
Although drug is classified as potential interaction, recommendation is to avoid coadministration